{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:10:11Z","timestamp":1793740211207,"version":"4.6.1"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221231-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Appropriate use of antibiotics is life-saving in neonatal early-onset sepsis (EOS), but overuse of antibiotics is associated with antimicrobial resistance and long-term adverse outcomes. Large international studies quantifying early-life antibiotic exposure along with EOS incidence are needed to provide a basis for future interventions aimed at safely reducing neonatal antibiotic exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi221231-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare early postnatal exposure to antibiotics, incidence of EOS, and mortality among different networks in high-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi221231-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This is a retrospective, cross-sectional study of late-preterm and full-term neonates born between January 1, 2014, and December 31, 2018, in 13 hospital-based or population-based networks from 11 countries in Europe and North America and Australia. The study included all infants born alive at a gestational age greater than or equal to 34 weeks in the participating networks. Data were analyzed from October 2021 to March 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi221231-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Exposure to antibiotics started in the first postnatal week.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi221231-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The main outcomes were the proportion of late-preterm and full-term neonates receiving intravenous antibiotics, the duration of antibiotic treatment, the incidence of culture-proven EOS, and all-cause and EOS-associated mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi221231-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 757\u202f979 late-preterm and full-term neonates were born in the participating networks during the study period; 21\u202f703 neonates (2.86%; 95% CI, 2.83%-2.90%), including 12\u202f886 boys (59.4%) with a median (IQR) gestational age of 39 (36-40) weeks and median (IQR) birth weight of 3250 (2750-3750) g, received intravenous antibiotics during the first postnatal week. The proportion of neonates started on antibiotics ranged from 1.18% to 12.45% among networks. The median (IQR) duration of treatment was 9 (7-14) days for neonates with EOS and 4 (3-6) days for those without EOS. This led to an antibiotic exposure of 135 days per 1000 live births (range across networks, 54-491 days per 1000 live births). The incidence of EOS was 0.49 cases per 1000 live births (range, 0.18-1.45 cases per 1000 live births). EOS-associated mortality was 3.20% (12 of 375 neonates; range, 0.00%-12.00%). For each case of EOS, 58 neonates were started on antibiotics and 273 antibiotic days were administered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi221231-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The findings of this study suggest that antibiotic exposure during the first postnatal week is disproportionate compared with the burden of EOS and that there are wide (up to 9-fold) variations internationally. This study defined a set of indicators reporting on both dimensions to facilitate benchmarking and future interventions aimed at safely reducing antibiotic exposure in early life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.43691","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T11:34:04Z","timestamp":1669203244000},"page":"e2243691","source":"Crossref","is-referenced-by-count":96,"title":["Analysis of Antibiotic Exposure and Early-Onset Neonatal Sepsis in Europe, North America, and Australia"],"prefix":"10.1001","volume":"5","author":[{"given":"Eric","family":"Giannoni","sequence":"first","affiliation":[{"name":"Clinic of Neonatology, Department Mother-Woman-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varvara","family":"Dimopoulou","sequence":"additional","affiliation":[{"name":"Clinic of Neonatology, Department Mother-Woman-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Klingenberg","sequence":"additional","affiliation":[{"name":"Paediatric Research Group, Faculty of Health Sciences, UiT-The Arctic University of Norway, Troms\u00f8, Norway"},{"name":"Department of Pediatrics and Adolescence Medicine, University Hospital of North Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Nav\u00e9r","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Karolinska University Hospital and Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka","family":"Nordberg","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Karolinska University Hospital and Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Berardi","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Mother and Child Department, Policlinico University Hospital, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salhab","family":"el Helou","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, McMaster Children\u2019s Hospital, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fusch","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, McMaster Children\u2019s Hospital, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Bliss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Women & Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Lehnick","sequence":"additional","affiliation":[{"name":"Biostatistics and Methodology, CTU-CS, Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Guerina","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Women & Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Seliga-Siwecka","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Maton","sequence":"additional","affiliation":[{"name":"Service N\u00e9onatal, Clinique CHC-Montlegia, Groupe Sant\u00e9 CHC, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatienne","family":"Lagae","sequence":"additional","affiliation":[{"name":"Neonatology and Neonatal Intensive Care Unit, CHIREC-Delta Hospital, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Mari","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Szeged, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Janota","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Department of Obstetrics and Gynecology, Motol University Hospital Prague, Prague, Czech Republic"},{"name":"Department of Pathological Physiology, 1st Medical School, Charles University Prague, Prague, Czech Republic"},{"name":"Department of Neonatology, Thomayer University Hospital Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp K. A.","family":"Agyeman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pfister","sequence":"additional","affiliation":[{"name":"Neonatology and Paediatric Intensive Care Unit, Geneva University Hospitals and Geneva University, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Latorre","sequence":"additional","affiliation":[{"name":"Neonatology and Neonatal Intensive Care Unit, Ecclesiastical General Hospital F. Miulli, Acquaviva delle Fonti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Maffei","sequence":"additional","affiliation":[{"name":"Neonatology and Neonatal Intensive Care Unit, Policlinico Riuniti Foggia, Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Laforgia","sequence":"additional","affiliation":[{"name":"Neonatologia e Terapia Intensiva Neonatale, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u0151","family":"M\u00f3zes","sequence":"additional","affiliation":[{"name":"Perinatal Intensive Care Unit, Department of Obstetrics and Gynaecology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketil","family":"St\u00f8rdal","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Strunk","sequence":"additional","affiliation":[{"name":"Neonatal Directorate, Child and Adolescent Health Service, King Edward Memorial Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stocker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital Lucerne, Lucerne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AENEAS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Capretti","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ceccoli","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"De Angelis","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Drimaco","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalyane","family":"Eap","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"el Helou","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Esmaeilizand","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Foglianese","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Geraci","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Grochowski","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stellan","family":"H\u00e5kansson","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharandeep","family":"Kaur","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Louise","family":"Kollegger","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Oldendorff","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Rizzo","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild E.","family":"R\u00f8nnestad","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damber","family":"Shrestha","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00f8rgen","family":"Stensvold","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Torregrossa","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Trefny","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Zilinska","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Zwijacz","sequence":"additional","affiliation":[{"name":"for the AENEAS Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"issue":"6","key":"zoi221231r1","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"zoi221231r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100727","article-title":"A global point prevalence survey of antimicrobial use in neonatal intensive care units: the no-more-antibiotics and resistance (NO-MAS-R) study.","volume":"32","author":"Prusakov","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"2","key":"zoi221231r3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/jpids\/piy019","article-title":"High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey.","volume":"8","author":"Hufnagel","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"zoi221231r5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkx426","article-title":"Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review.","volume":"73","author":"Fjalstad","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"10325","key":"zoi221231r6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"zoi221231r7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2437","article-title":"The role of the microbiome in the developmental origins of health and disease.","volume":"141","author":"Stiemsma","year":"2018","journal-title":"Pediatrics"},{"key":"zoi221231r8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1729560","article-title":"The association between prolonged antibiotic use in culture negative infants and length of hospital stay and total hospital costs.","author":"Sourour","year":"2021","journal-title":"Am J Perinatol"},{"key":"zoi221231r9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpeds.2021.08.075","article-title":"Medication use in the neonatal intensive care unit and changes from 2010 to 2018.","volume":"240","author":"Stark","year":"2022","journal-title":"J Pediatr"},{"key":"zoi221231r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.100255","article-title":"Finding a role for the neonatal early-onset sepsis risk calculator.","volume":"19","author":"Benitz","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"11","key":"zoi221231r11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/jamapediatrics.2019.2825","article-title":"Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis.","volume":"173","author":"Achten","year":"2019","journal-title":"JAMA Pediatr"},{"key":"zoi221231r12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fped.2018.00285","article-title":"Culture-negative early-onset neonatal sepsis: at the crossroad between efficient sepsis care and antimicrobial stewardship.","volume":"6","author":"Klingenberg","year":"2018","journal-title":"Front Pediatr"},{"issue":"2","key":"zoi221231r13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.idc.2014.01.005","article-title":"Antimicrobial stewardship in the NICU.","volume":"28","author":"Cantey","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"zoi221231r14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/archdischild-2019-318026","article-title":"Effectiveness of antimicrobial stewardship programmes in neonatology: a systematic review.","volume":"105","author":"Araujo da Silva","year":"2020","journal-title":"Arch Dis Child"},{"issue":"8","key":"zoi221231r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2020.151329","article-title":"Metrics of neonatal antibiotic use.","volume":"44","author":"Flannery","year":"2020","journal-title":"Semin Perinatol"},{"issue":"10","key":"zoi221231r16","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/S1473-3099(16)30082-2","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research.","volume":"16","author":"Fitchett","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"zoi221231r17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamapediatrics.2016.4678","article-title":"A quantitative, risk-based approach to the management of neonatal early-onset sepsis.","volume":"171","author":"Kuzniewicz","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"3","key":"zoi221231r18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1542\/peds.2012-1999","article-title":"Levels of neonatal care.","volume":"130","author":"American Academy of Pediatrics Committee on Fetus And Newborn","year":"2012","journal-title":"Pediatrics"},{"key":"zoi221231r19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jpeds.2018.05.048","article-title":"Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset: a prospective population-based cohort study.","volume":"201","author":"Giannoni","year":"2018","journal-title":"J Pediatr"},{"issue":"6","key":"zoi221231r20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2013","article-title":"Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014.","volume":"138","author":"Schrag","year":"2016","journal-title":"Pediatrics"},{"issue":"7","key":"zoi221231r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.0593","article-title":"Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies.","volume":"174","author":"Stoll","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"6","key":"zoi221231r22","doi-asserted-by":"publisher","first-page":"F547","DOI":"10.1136\/archdischild-2017-313203","article-title":"Epidemiology of UK neonatal infections: the neonIN Infection Surveillance Network.","volume":"103","author":"Cailes","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"zoi221231r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214298","article-title":"Epidemiology of neonatal early-onset sepsis in a geographically diverse Australian health district 2006-2016.","volume":"14","author":"Braye","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"zoi221231r24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1105","article-title":"Newborn antibiotic exposures and association with proven bloodstream infection.","volume":"144","author":"Schulman","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"zoi221231r25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1542\/peds.2013-1689","article-title":"Stratification of risk of early-onset sepsis in newborns = 34 weeks\u2019 gestation.","volume":"133","author":"Escobar","year":"2014","journal-title":"Pediatrics"},{"issue":"6","key":"zoi221231r26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051339","article-title":"Antibiotic use in term and near-term newborns.","volume":"148","author":"Mundal","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"zoi221231r27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/archdischild-2020-321489","article-title":"Implementation of an adapted Sepsis Risk Calculator algorithm to reduce antibiotic usage in the management of early onset neonatal sepsis: a multicentre initiative in Wales, UK.","volume":"107","author":"Goel","year":"2022","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"zoi221231r28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MOP.0000000000000864","article-title":"Serial clinical observation for management of newborns at risk of early-onset sepsis.","volume":"32","author":"Berardi","year":"2020","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"zoi221231r29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/INF.0000000000002590","article-title":"Reduced antibiotic exposure by serial physical examinations in term neonates at risk of early-onset sepsis.","volume":"39","author":"Vatne","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"zoi221231r30","doi-asserted-by":"publisher","DOI":"10.4414\/smw","article-title":"Reduction in the use of diagnostic tests in infants with risk factors for early-onset neonatal sepsis does not delay antibiotic treatment.","volume":"144","author":"Duvoisin","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"zoi221231r31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1542\/peds.2014-3409","article-title":"Neonatal intensive care unit antibiotic use.","volume":"135","author":"Schulman","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"zoi221231r32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/INF.0000000000001063","article-title":"Variation in current management of term and late-preterm neonates at risk for early-onset sepsis: an international survey and review of guidelines.","volume":"35","author":"van Herk","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"zoi221231r33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fped.2018.00294","article-title":"Impact of empowering leadership on antimicrobial stewardship: a single center study in a neonatal and pediatric intensive care unit and a literature review.","volume":"6","author":"Steinmann","year":"2018","journal-title":"Front Pediatr"},{"issue":"2","key":"zoi221231r34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jhin.2020.03.028","article-title":"The role of education in antimicrobial stewardship.","volume":"105","author":"Satterfield","year":"2020","journal-title":"J Hosp Infect"},{"issue":"3","key":"zoi221231r35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1515\/jpm-2016-0200","article-title":"Underlying causes of neonatal deaths in term singleton pregnancies: home births versus hospital births in the United States.","volume":"45","author":"Gr\u00fcnebaum","year":"2017","journal-title":"J Perinat Med"},{"issue":"10097","key":"zoi221231r36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","article-title":"Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).","volume":"390","author":"Stocker","year":"2017","journal-title":"Lancet"},{"key":"zoi221231r4","unstructured":"World Health Organization. World Health Assembly 69. Global action plan on antimicrobial resistance: options for establishing a global development and stewardship framework to support the development, control, distribution and appropriate use of new antimicrobial medicines, diagnostic tools, vaccines and other interventions\u2014report by the Secretariat. 2016. Accessed April 5, 2022. https:\/\/apps.who.int\/iris\/handle\/10665\/252682"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2798898\/giannoni_2022_oi_221231_1668537393.86804.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T11:34:08Z","timestamp":1669203248000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.43691","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}